Published on: April 15, 2019 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo
Sponsor:   Novo Nordisk A/S
Not yet recruiting
http://bit.ly/2PaFGLs

0 Comments